Charlotte Eye Ear Nose & Throat Associates, P.A.

Statesville, North Carolina 28677

We've found

1 trials

at this facility

Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF

Status: Enrolling, Phase II
Updated: 4/18/2018

from

Statesville, NC

Use our guide to learn which trials are right for you!